Edition:
United States

Neptune Technologies & Bioressources Inc (NEPT.TO)

NEPT.TO on Toronto Stock Exchange

4.30CAD
13 Jul 2018
Change (% chg)

$-0.25 (-5.49%)
Prev Close
$4.55
Open
$4.61
Day's High
$4.62
Day's Low
$4.17
Volume
440,691
Avg. Vol
281,952
52-wk High
$5.94
52-wk Low
$0.86

Chart for

About

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products... (more)

Overall

Beta: 0.57
Market Cap(Mil.): $340.62
Shares Outstanding(Mil.): 79.21
Dividend: --
Yield (%): --

Financials

  NEPT.TO Industry Sector
P/E (TTM): 19.49 29.26 33.20
EPS (TTM): 0.22 -- --
ROI: 11.02 13.66 13.23
ROE: 23.33 15.51 15.28

BRIEF-Neptune Technologies & Bioressources Q3 ‍Net Income $1.3 Mln Vs $9.4 Mln

Feb 14 Neptune Technologies & Bioressources Inc :

Feb 14 2018

BRIEF-Neptune, Tetra Bio-Pharma Enter Co-Development Agreement For Purified Cannabinoid Oil-Based Products Targeting Pain, Inflammation

* NEPTUNE AND TETRA BIO-PHARMA ENTER CO-DEVELOPMENT AGREEMENT FOR PURIFIED CANNABINOID OIL-BASED PRODUCTS TARGETING PAIN AND INFLAMMATION Source text for Eikon: Further company coverage:

Feb 12 2018

BRIEF-Neptune And Tetra Bio-Pharma Sign Co-Development Agreement

* NEPTUNE AND TETRA BIO-PHARMA ENTER CO-DEVELOPMENT AGREEMENT FOR PURIFIED CANNABINOID OIL-BASED PRODUCTS TARGETING PAIN AND INFLAMMATION

Feb 12 2018

Earnings vs. Estimates